Wegovy cost without insurance is a tale of two price tags. One cash-pay telehealth menu lists the brand pen from $1,579 a month. Third-party reports from March 2026 put retail Wegovy near $1,999. Yet Ro and Hers sell the exact same FDA-approved pen from $199 a month. Same drug. Same doses. Roughly an 87% gap.

The catch lives in the fine print, and this page reads all of it. The $199 telehealth prices sit on top of $149 monthly membership fees. Pen prices climb as your dose climbs — up to $399 at Ro. And the true budget path, compounded semaglutide at $99 to $299 a month, is not FDA-approved. Below: the full cash-cost landscape, the membership math, and five programs ranked as cheaper routes to semaglutide.

What Does Wegovy Really Cost Without Insurance in 2026?

Start with what Wegovy is. It’s semaglutide 2.4 mg, FDA-approved for chronic weight management in June 2021 — the first new weight-loss drug approval since 2014. In the STEP 1 trial, adults taking it lost an average of 14.9% of body weight over 68 weeks. That result built a drug with four-figure sticker prices and a crowd of discounters underneath.

Here’s the cash spread in July 2026:

Where you buy Wegovy cash price What’s included
Cash-pay telehealth menu (altRx listing) From $1,579/mo Medication only
Retail out-of-pocket, per third-party reports (March 2026) About $1,999/mo Medication only
Ro — Wegovy pen $199 first month, then $199-$399/mo Care team; $149/mo membership extra
Hers — Wegovy pen From $199/mo Provider messaging; $149/mo membership extra
Hers or Ro — Wegovy pill From $149/mo (intro at Ro) Oral semaglutide; membership extra
Compounded semaglutide (not Wegovy) $99-$299/mo Not FDA-approved; usually all-inclusive

Two things jump out. First, nobody should pay a four-figure cash price when the identical FDA-approved pen sells for $199 through licensed telehealth. Ro even publishes that its prices match Novo Nordisk’s own NovoCare channel. Second, no headline telehealth price is complete. The membership fee is the half of the bill the ads skip.

How Does the $149 Membership Fee Change the Math?

Both discount Wegovy sellers run a two-bill model. Medication is one charge. Membership is another. Miss that and your budget is off by roughly $1,800 a year.

At Hers, membership costs $39 the first month, then $149/month, auto-renewing and billed separately. Hers’ own site says the membership does not include or guarantee a prescription. At Ro, the structure is identical — $39, then $149/month — with two softeners: annual prepay cuts it to as low as $74/month, and Ro charges the fee only if you’re found eligible for treatment.

Here’s what real totals look like:

Program and format First-month total Ongoing monthly total
Ro — Wegovy pill ($149) + membership ($39) $188 $348-$448 ($273-$373 with prepaid membership)
Ro — Wegovy pen ($199) + membership ($39) $238 $348-$548 ($273-$473 with prepaid membership)
Hers — Wegovy pill + membership + $5 shipping About $193, per third-party reports About $303, per third-party reports
Hers — Wegovy pen + membership About $243 About $348 before shipping

So the honest answer to what Wegovy costs without insurance in 2026: about $303 to $548 a month all-in through telehealth, depending on format and dose. Painful, but 70-85% below the four-figure listings. Now the five programs, ranked.

1. Ro — Brand Wegovy at Manufacturer-Direct Prices

Score: 8.8 (Very Good). Ro leads because it sells only FDA-approved, brand-name GLP-1s — zero compounded copies on its July 2026 pricing page — and prices them at what it says are manufacturer-direct rates. The Wegovy pen costs $199 the first month, then $199 to $399 by dose. The Wegovy pill starts at $149, then $199 to $299. Ro states these cash prices match NovoCare, LillyDirect, and TrumpRx.

The sourcing is the real story. Novo Nordisk named Ro a direct partner in April 2025, so pens ship through the manufacturer’s own NovoCare Pharmacy. In January 2026, Ro was among the first telehealth platforms to carry the Wegovy pill. And before you pay cash at all, Ro checks your insurance for free — its concierge files prior-authorization paperwork, and with coverage the drug can drop to a copay.

The fine print: membership runs $39, then $149/month, or as low as $74/month prepaid annually (Ro claims up to $900/year in savings). Ro’s own FAQ confirms Wegovy’s price increases at higher doses. Reputation is mixed — Trustpilot about 3.7/5 across 2,300+ reviews and 610 BBB complaints (B rating, accredited since 2018), with recurring gripes about membership billing, per Forbes Health and BBB records. You also must have seen a healthcare provider within the last 3 years to qualify.

Pricing Structure

Item First month Then
Wegovy pen $199 $199-$399/mo by dose
Wegovy pill $149 $199-$299/mo, cash-pay only
Membership $39 $149/mo, or as low as $74/mo prepaid annually
Ozempic (off-label) $900-$1,100/mo at the pharmacy

A Prepay & Save option cuts up to $150/month off the highest Wegovy pen dose on the annual plan.

Pros & Cons

Pros:

  • FDA-approved brand-name GLP-1s only; sourced via NovoCare and LillyDirect
  • Cash prices stated to match manufacturer-direct channels
  • Free insurance check and prior-auth concierge before you commit to cash
  • Membership charged only if you’re found eligible; serves all 50 states plus D.C.

Cons:

  • $149/month membership on the monthly plan nearly doubles the pill’s real cost
  • Top-dose pen hits $399/month — $548 all-in with monthly membership
  • Trustpilot ~3.7/5 and 610 BBB complaints, many about membership billing
  • Wegovy pill is cash-pay only, and no refund policy was found on pages reviewed

2. Noom Med — the $99 Wrapper That Doesn’t Include the Drug

Score: 8.7 (Very Good). Noom Med attacks the membership fee instead of the drug price. Its branded-medication plan costs $39 the first month, then $99/month billed quarterly — a third less than the $149 wrappers at Ro and Hers. That buys clinician visits, prescription management, and the full Noom coaching app the company has built since 2008. Wegovy, Ozempic, Zepbound, Mounjaro, and the Wegovy pill are all on the menu.

Read the asterisk twice: the medication is not included. Noom coordinates your prescription through insurance or cash pay, and Noom itself discloses that brand-name GLP-1s can run about $1,000+/month without coverage. So the $99 plan shines if insurance covers your Wegovy — and loses to Ro’s $199 pens if you’re paying pure cash for the drug.

Noom’s real cash play is its compounded line: semaglutide at $129 the first month, then $249/month billed quarterly, or a microdose tier at $79 then $199/month. Those are flat subscription prices with medication included — but compounded semaglutide is not FDA-approved, and Noom’s own disclaimer says the FDA has not reviewed it for safety, efficacy, or quality. Compounded plans skip Alabama, Louisiana, and Mississippi. Trust marks are solid: BBB A+, accredited since 2021, plus a Taper-Off Guarantee covering regain within 18 months after a 12-month course.

Pricing Structure

Plan First month Then
Branded-med telehealth plan (Wegovy path) $39 $99/mo billed quarterly + medication cost
Compounded semaglutide (GLP-1Rx) $129 $249/mo billed quarterly
Microdose compounded semaglutide $79 $199/mo billed quarterly
Metformin pill plan $69 $99/mo billed quarterly

Note the billing rhythm: after month one, charges land quarterly — $537 to $837 per 12 weeks on compounded plans. Noom’s own pages also showed conflicting renewal rates ($249 vs $279) in July 2026.

Pros & Cons

Pros:

  • Cheapest clinician wrapper here: $39, then $99/month for the brand-drug path
  • Coaching app and behavior program bundled into every plan
  • BBB A+ since 2021; Taper-Off Guarantee is unique in this market
  • Compounded fallback from $129 first month if brand Wegovy is out of reach

Cons:

  • Wegovy itself bills separately — $1,000+/month cash per Noom’s own disclosure
  • Quarterly lump billing of $537+ after the promo month on compounded plans
  • Compounded semaglutide is not FDA-approved; unavailable in AL, LA, MS
  • No published refund policy beyond cancel anytime

3. Hers — Wegovy Pills From $149, Plus a Second $149 Bill

Score: 8.5 (Very Good). Hers lists the cheapest FDA-approved Wegovy entry on this page: the Wegovy pill from $149/month, with the pen from $199. The women’s arm of NYSE-listed Hims & Hers runs asynchronous visits — no video call in most states, no lab work, provider review typically within 24 hours — across all 50 states.

Then the second bill arrives. Membership costs $39 the first month, then $149/month, billed separately, and per Hers’ own site it neither includes nor guarantees a prescription. Third-party pricing reports from July 2026 put the cheapest real-world math at about $193 for the first month (with $5 shipping) and about $303/month ongoing. Insurance is not accepted at all. For contrast, Hers’ own pricing page lists retail Mounjaro and Zepbound pens at $1,899/month — and third-party reporting from March 2026 put cash Wegovy near $1,999 — so $303-$348 all-in is still a fraction of sticker.

The record has scars. The FDA sent Hers a warning letter on September 9, 2025 over false or misleading marketing of compounded semaglutide — which is not FDA-approved — and Novo Nordisk sued its parent in February 2026 over those compounded products. Hers has since pivoted to brand-name drugs, limiting compounded semaglutide to medical necessity as of March 2026. It holds a BBB A+ and about 3.8/5 across roughly 7,000 customer reviews, per third-party reporting. Refund window: 48 hours, unshipped orders only — and canceling medication does not cancel the membership.

Pricing Structure

Item Price Fine print
Wegovy pill From $149/mo From-pricing; rises with dose
Wegovy pen From $199/mo Same from-pricing caveat
Zepbound vial or KwikPen From $299/mo Retail pens listed at $1,899/mo
Membership $39 first month, then $149/mo Required; does not guarantee a prescription

Pros & Cons

Pros:

  • Cheapest FDA-approved listing here: Wegovy pill from $149/month
  • About $303/month real ongoing total, per third-party pricing reports
  • All 50 states, async visits, no labs, ~24-hour provider review
  • BBB A+; backed by a publicly traded parent operating since 2017

Cons:

  • Mandatory $149/month membership roughly doubles the pill’s cost
  • September 2025 FDA warning letter and a February 2026 Novo Nordisk lawsuit
  • No insurance accepted; from-prices climb with dose and full tiers aren’t published
  • 48-hour refund window; canceling meds doesn’t cancel the membership

4. bmiMD — Skip the Brand, Pay $99 for Compounded Semaglutide

Score: 8.2 (Very Good). bmiMD doesn’t sell Wegovy at all — no pen, no pill, no brand anything. It sells compounded semaglutide from $99/month, and we’ll say it plainly: compounded semaglutide is not FDA-approved, and bmiMD’s own site discloses the FDA hasn’t evaluated it for safety, efficacy, or quality. What bmiMD offers is the cheapest semaglutide math on this page for people who accept that trade-off.

The pricing is refreshingly flat. $99/month on the 12-month plan — billed as $1,188 upfront — $109 on six months, $119 on three, or $129 month-to-month. There’s no membership fee: the price bundles the telehealth visit, medication, unlimited provider messaging, and refills. And it’s the same price at every dose, a direct contrast to Ro’s $199-to-$399 climb. HSA/FSA cards work, buy-now-pay-later is offered, shipping is free, and your card is only authorized — not charged — until a provider approves you.

The trade-offs beyond FDA status: the best rates demand multi-month prepays ($1,188 at once for the $99 rate). Cancel between intake approval and pharmacy processing and you owe a $50 fee; after the pharmacy processes, all sales are final. The company holds a BBB C+ with 38 complaints and no accreditation, against a Trustpilot average around 4 stars across 800+ reviews, per July 2026 snapshots. It also doesn’t name its compounding pharmacy partners.

Pricing Structure

Plan Price Billing
Compounded semaglutide, 12-month $99/mo $1,188 billed upfront
Compounded semaglutide, 6-month $109/mo $654 billed upfront
Compounded semaglutide, monthly $129/mo Month-to-month
Compounded tirzepatide $139-$159/mo $89.50 first month on new-member promo

Pros & Cons

Pros:

  • Cheapest semaglutide here: $99/month prepaid, $129 month-to-month
  • No membership fee — visit, meds, and messaging in one price
  • Same price at every dose; no charge if you’re found ineligible
  • HSA/FSA accepted, buy-now-pay-later available, free shipping

Cons:

  • Compounded only — no FDA-approved Wegovy option exists here
  • $99 rate requires a $1,188 upfront commitment
  • $50 cancellation fee window; all sales final after pharmacy processing
  • BBB C+ with 38 complaints; unnamed pharmacy partners

5. MEDVi — Flat $299 Refills and an F From the BBB

Score: 7.6 (Good). MEDVi runs two routes to semaglutide. Route one: brand-name Wegovy for a $99 membership plus medication cost — a cheaper wrapper than Ro’s or Hers’ $149, but MEDVi doesn’t publish the medication price upfront, so the total is a question mark until checkout. Route two: compounded semaglutide at $179 the first month, then a flat $299/month — all-inclusive, with consult, medication, expedited shipping, and support bundled, and no dose-based increases. It also sells daily dissolvable semaglutide tablets from $249 first month, a rare non-injection option. Standard disclosure applies: the compounded products are not FDA-approved, as MEDVi’s own site states.

Now the fine print, and there’s a lot. The $179 intro jumps 67% to $299 on refills. MEDVi holds a BBB F rating with 662 complaints — 100 unanswered — against a Trustpilot score around 4.4/5 across roughly 14,000 reviews. That’s the widest trust gap on this page. Complaints repeatedly cite surprise auto-renewals (often $399), double billing, and cancellation trouble. One review site reports billing on a 28-day cycle, which means about 13 charges a year, not 12 — per third-party reports. Refunds are generally gone once a cycle’s medication is dispensed, and service covers 49 states, not 50.

Pricing Structure

Item First month Then
Compounded semaglutide injection $179 $299/mo flat, all-inclusive
Compounded semaglutide tablets $249 Refill price not published; up to $369 per third-party reviews
Compounded tirzepatide From $349 $399-$499/mo per third-party reports
Brand Wegovy or Zepbound $99 membership Plus unpublished medication cost

Pros & Cons

Pros:

  • Flat $299 refills that don’t rise with dose; no fee on compounded plans
  • $99-membership route to genuine brand Wegovy exists
  • Oral dissolvable tablets offered — rare among GLP-1 telehealth sellers
  • Trustpilot ~4.4/5 across ~14,000 reviews; names its pharmacy partners

Cons:

  • BBB F rating, 662 complaints, 100 unanswered as of July 2026
  • 67% price jump after the $179 first month
  • Reported 28-day billing means roughly 13 charges a year
  • Brand Wegovy medication price isn’t published; refunds nearly nonexistent

Why Does Wegovy Cost More as Your Dose Goes Up?

Because the FDA label moves everyone up. Wegovy starts at 0.25 mg weekly and steps up roughly every four weeks — 0.5 mg, 1 mg, 1.7 mg — until you reach the 2.4 mg maintenance dose around month five, per the prescribing information. You don’t stay at the starter dose. The pricing follows: Ro’s own FAQ says Wegovy’s price increases at higher doses, which is how a $199 first month becomes $399/month at maintenance. Hers uses from-pricing that climbs the same way without publishing the full tiers.

So run your budget on the maintenance price, not the ad. At Ro, that’s up to $548/month with a monthly membership. The flat-price crowd — bmiMD at $99-$129 and MEDVi at $299 — advertises the same price at every dose, but only on compounded products. Map your own titration against the Wegovy dosage schedule before you commit to any plan.

Is Compounded Semaglutide a Safe Way to Pay Less?

It’s the cheapest way — $99 to $299 a month versus $348+ all-in for a brand pen — and it’s the riskiest. Let’s be exact: no compounded semaglutide is FDA-approved, at any price, from any seller. The FDA has not evaluated these pharmacy-made copies for safety, effectiveness, or quality, and it has published specific concerns about unapproved GLP-1 drugs, including dosing errors and unverified ingredients.

The enforcement record backs that up. The FDA announced more than 55 warning letters to compounded GLP-1 sellers in September 2025 — Hers among the recipients. And the legal window has narrowed: the FDA declared the semaglutide shortage resolved in February 2025, ending the mass-compounding allowances that built this market. That’s why Ro’s menu now carries zero compounded drugs and Hers limits them to medical necessity. If you go this route anyway, favor sellers that disclose testing and pharmacy details, and see where every branded and compounded option sits on the full GLP-1 drug list first.

How Long Will You Be Paying These Prices?

Longer than the promo month — plan on that. STEP 1, the trial behind Wegovy’s approval, ran 68 weeks to reach that average 14.9% loss. That’s roughly 16 months. The NIDDK notes prescription weight drugs are intended for long-term chronic weight management, not a six-week sprint, and most people see gradual results — here’s how fast GLP-1s work in practice.

Now multiply. Sixteen months at Hers’ reported $303/month all-in is about $4,850. Ro’s pen at maintenance dose with monthly membership — $548 — totals about $8,770. And the four-figure listings? Sixteen months at $1,579 is over $25,000, which is the strongest argument on this page for never paying retail cash. First-month promos ($179, $188, $193) are rounding errors against these totals. The renewal price is the real price.

How Did We Rank These Five Programs?

By the numbers that hit your card, not the ones in the ads. We scored each program on real ongoing cost with membership fees included, pricing transparency (published dose tiers beat from-pricing), FDA status of what’s actually sold, and documented trust records — BBB files, Trustpilot patterns, FDA warning letters, and refund terms. Ro’s 8.8 reflects manufacturer-direct sourcing at $199-$399 plus a real membership drag; MEDVi’s 7.6 reflects a flat $299 price fighting a BBB F rating. Every score comes from documented research on pricing pages and regulator records, and the full methodology is at how we rank.